Literature DB >> 26923594

Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.

Jun Hyoung Park1, Sajna Vithayathil1, Santosh Kumar1, Pi-Lin Sung2, Lacey Elizabeth Dobrolecki3, Vasanta Putluri4, Vadiraja B Bhat5, Salil Kumar Bhowmik4, Vineet Gupta1, Kavisha Arora1, Danli Wu6, Efrosini Tsouko7, Yiqun Zhang8, Suman Maity4, Taraka R Donti1, Brett H Graham1, Daniel E Frigo9, Cristian Coarfa4, Patricia Yotnda6, Nagireddy Putluri4, Arun Sreekumar10, Michael T Lewis11, Chad J Creighton8, Lee-Jun C Wong12, Benny Abraham Kaipparettu13.   

Abstract

Transmitochondrial cybrids and multiple OMICs approaches were used to understand mitochondrial reprogramming and mitochondria-regulated cancer pathways in triple-negative breast cancer (TNBC). Analysis of cybrids and established breast cancer (BC) cell lines showed that metastatic TNBC maintains high levels of ATP through fatty acid β oxidation (FAO) and activates Src oncoprotein through autophosphorylation at Y419. Manipulation of FAO including the knocking down of carnitine palmitoyltransferase-1A (CPT1) and 2 (CPT2), the rate-limiting proteins of FAO, and analysis of patient-derived xenograft models confirmed the role of mitochondrial FAO in Src activation and metastasis. Analysis of TCGA and other independent BC clinical data further reaffirmed the role of mitochondrial FAO and CPT genes in Src regulation and their significance in BC metastasis.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26923594      PMCID: PMC4809061          DOI: 10.1016/j.celrep.2016.02.004

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  65 in total

Review 1.  Mitochondrion as a novel target of anticancer chemotherapy.

Authors:  P Costantini; E Jacotot; D Decaudin; G Kroemer
Journal:  J Natl Cancer Inst       Date:  2000-07-05       Impact factor: 13.506

2.  Transmitochondrial cybrids: tools for functional studies of mutant mitochondria.

Authors:  Sajna Antony Vithayathil; Yewei Ma; Benny Abraham Kaipparettu
Journal:  Methods Mol Biol       Date:  2012

3.  Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing.

Authors:  Christina I Herold; Vijaya Chadaram; Bercedis L Peterson; P Kelly Marcom; Judith Hopkins; Gretchen G Kimmick; Justin Favaro; Erika Hamilton; Renee A Welch; Sarah Bacus; Kimberly L Blackwell
Journal:  Clin Cancer Res       Date:  2011-08-02       Impact factor: 12.531

Review 4.  Src kinases are important regulators of mitochondrial functions.

Authors:  Etienne Hebert-Chatelain
Journal:  Int J Biochem Cell Biol       Date:  2012-08-20       Impact factor: 5.085

Review 5.  Non-glucose metabolism in cancer cells--is it all in the fat?

Authors:  Swethajit Biswas; John Lunec; Kim Bartlett
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 6.  Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

Authors:  Brian O'Rourke; Jennifer E Van Eyk; D Brian Foster
Journal:  Congest Heart Fail       Date:  2011-11-09

Review 7.  Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.

Authors:  Erica L Mayer; Ian E Krop
Journal:  Clin Cancer Res       Date:  2010-07-15       Impact factor: 12.531

8.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

9.  Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancer.

Authors:  Muralidharan Anbalagan; Krzysztof Moroz; Alaa Ali; Latonya Carrier; Seth Glodowski; Brian G Rowan
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

10.  Regulation of cytochrome c oxidase activity by c-Src in osteoclasts.

Authors:  Tsuyoshi Miyazaki; Lynn Neff; Sakae Tanaka; William C Horne; Roland Baron
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

View more
  104 in total

Review 1.  Adipocyte and lipid metabolism in cancer drug resistance.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

2.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 3.  Mitochondrial Involvement in Migration, Invasion and Metastasis.

Authors:  Tatiana V Denisenko; Anna S Gorbunova; Boris Zhivotovsky
Journal:  Front Cell Dev Biol       Date:  2019-12-20

4.  The macroenviromental control of cancer metabolism by p62.

Authors:  Jianfeng Huang; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

5.  Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.

Authors:  Dongya Jia; Mingyang Lu; Kwang Hwa Jung; Jun Hyoung Park; Linglin Yu; José N Onuchic; Benny Abraham Kaipparettu; Herbert Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-07       Impact factor: 11.205

6.  CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.

Authors:  Naoto Fujiwara; Hayato Nakagawa; Kenichiro Enooku; Yotaro Kudo; Yuki Hayata; Takuma Nakatsuka; Yasuo Tanaka; Ryosuke Tateishi; Yohko Hikiba; Kento Misumi; Mariko Tanaka; Akimasa Hayashi; Junji Shibahara; Masashi Fukayama; Junichi Arita; Kiyoshi Hasegawa; Hadassa Hirschfield; Yujin Hoshida; Yoshihiro Hirata; Motoyuki Otsuka; Keisuke Tateishi; Kazuhiko Koike
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

7.  The combined expressions of B7H4 and ACOT4 in cancer-associated fibroblasts are related to poor prognosis in patients with gastric carcinoma.

Authors:  Qing Li; Yu'e Yang; Xin Jiang; Yufen Jin; Jingyi Wu; Yan Qin; Xiaowei Qi; Yang Cheng; Yong Mao; Dong Hua
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

8.  Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.

Authors:  Larissa Menezes Dos Reis; Douglas Adamoski; Rodolpho Ornitz Oliveira Souza; Carolline Fernanda Rodrigues Ascenção; Krishina Ratna Sousa de Oliveira; Felipe Corrêa-da-Silva; Fábio Malta de Sá Patroni; Marília Meira Dias; Sílvio Roberto Consonni; Pedro Manoel Mendes de Moraes-Vieira; Ariel Mariano Silber; Sandra Martha Gomes Dias
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

9.  Depletion of the Human Ion Channel TRPM2 in Neuroblastoma Demonstrates Its Key Role in Cell Survival through Modulation of Mitochondrial Reactive Oxygen Species and Bioenergetics.

Authors:  Lei Bao; Shu-Jen Chen; Kathleen Conrad; Kerry Keefer; Thomas Abraham; John P Lee; JuFang Wang; Xue-Qian Zhang; Iwona Hirschler-Laszkiewicz; Hong-Gang Wang; Sinisa Dovat; Brian Gans; Muniswamy Madesh; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

Review 10.  The multifaceted roles of fatty acid synthesis in cancer.

Authors:  Florian Röhrig; Almut Schulze
Journal:  Nat Rev Cancer       Date:  2016-09-23       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.